-transparent.png){kind=logo}
We studied the effect of human leukocyte interferon (HuIFN-alpha) on a human osteosarcoma (OS-OH) transplanted and passed serially in athymic mice. The growth of OS-OH was strikingly inhibited by HuIFN-alpha (50,000 IU/mouse), regardless of whether the interferon treatment was initiated 24 hr after tumor inoculation or 2 weeks later, when tumors had grown to an appreciable size (4-6 mm). The antitumor effect of HuIFN-alpha was found to be dose-dependent and a daily administration of HuIFN-alpha (50,000 IU/mouse) all but completely arrested the tumor growth.
Related Publications
S Masuda, and
H Fukuma, and
Y Beppu
November 1986,
Journal of pharmacobio-dynamics,
S Masuda, and
H Fukuma, and
Y Beppu
February 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Masuda, and
H Fukuma, and
Y Beppu
December 1984,
Journal of pharmacobio-dynamics,
S Masuda, and
H Fukuma, and
Y Beppu
November 1980,
Fukuoka igaku zasshi = Hukuoka acta medica,
S Masuda, and
H Fukuma, and
Y Beppu
January 1987,
Acta obstetricia et gynecologica Scandinavica,
S Masuda, and
H Fukuma, and
Y Beppu
October 1983,
Gan,
S Masuda, and
H Fukuma, and
Y Beppu
April 1983,
Gan,
S Masuda, and
H Fukuma, and
Y Beppu
September 1982,
Nihon Sanka Fujinka Gakkai zasshi,
S Masuda, and
H Fukuma, and
Y Beppu
October 1991,
Acta orthopaedica Scandinavica,
S Masuda, and
H Fukuma, and
Y Beppu
November 1988,
Nihon Seikeigeka Gakkai zasshi,
